Kenvue rises after report Third Point Capital has built a stake
Shares of Tylenol maker Kenvue KVUE.N rise 2.13% to $23.24
Dan Loeb's Third Point has built a stake in the company, the Financial Times reports, citing people familiar with the matter
The size of Third Point's stake and the extent to which the hedge fund has engaged with Kenvue could not immediately be established, FT said
Kenvue did not immediately respond to a Reuters request for comment
In March, Kenvue appointed three new directors to its board as part of an agreement with activist investor Starboard Value
Up to last close, stock has risen 9.7% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?

Meta Stock Price Forecast 2026-2030: Can META Hit $1,000?

Big Tech’s AI Data Center Power Demands Trigger $15B PJM Auction and a Nuclear SMR Boom

Tradingkey







